Laura Mezquita, Mª Teófila Vicente-Herrero, Patricia Cruz, Mª Victoria Ramírez Íñiguez de la Torre, Julia Hidalgo-Coloma, Luisa Capdevila García, Oscar Gallego, Aitana Calvo, Katerine Martínez, Javier Pérez-Altozano, Raquel Molina, Miguel García-Pardo, Laura Gutiérrez-Sainz, Elena Moreno-Atahonero, Martín Oré-Arce, César Serrano, María Jesús Terradillos-García, María Rosario Valero, Luís Reinoso-Barbero, César A Rodríguez, Beatriz Calvo-Cerrada
{"title":"SEOM-AEEMT consensus on occupational cancer and cancer-associated disability.","authors":"Laura Mezquita, Mª Teófila Vicente-Herrero, Patricia Cruz, Mª Victoria Ramírez Íñiguez de la Torre, Julia Hidalgo-Coloma, Luisa Capdevila García, Oscar Gallego, Aitana Calvo, Katerine Martínez, Javier Pérez-Altozano, Raquel Molina, Miguel García-Pardo, Laura Gutiérrez-Sainz, Elena Moreno-Atahonero, Martín Oré-Arce, César Serrano, María Jesús Terradillos-García, María Rosario Valero, Luís Reinoso-Barbero, César A Rodríguez, Beatriz Calvo-Cerrada","doi":"10.1007/s12094-025-04037-2","DOIUrl":null,"url":null,"abstract":"<p><p>Cancer is one of the main causes of morbidity and mortality in Spain and has a significant impact in the workplace, where exposure to carcinogens in the work environment can increase the risk of developing this disease. The lack of communication between oncologists and occupational physicians limits the accurate assessment of cancer as an occupational disease and as a cause of disability. In 2020, the Spanish Society of Medical Oncology (SEOM) and the Spanish Association of Occupational Medicine Specialists (AEEMT) launched a joint initiative to strengthen prevention, reporting, and management of occupational cancer. This consensus provides a structured framework for assessing the occupational origin of cancer, facilitating case notification and classification as occupational contingencies, and supporting informed evaluations of disability and work reintegration in patients with cancer. The collaboration between both societies aims not only to advance occupational cancer prevention but also to promote evidence-based strategies for return-to-work planning.</p>","PeriodicalId":50685,"journal":{"name":"Clinical & Translational Oncology","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12094-025-04037-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Cancer is one of the main causes of morbidity and mortality in Spain and has a significant impact in the workplace, where exposure to carcinogens in the work environment can increase the risk of developing this disease. The lack of communication between oncologists and occupational physicians limits the accurate assessment of cancer as an occupational disease and as a cause of disability. In 2020, the Spanish Society of Medical Oncology (SEOM) and the Spanish Association of Occupational Medicine Specialists (AEEMT) launched a joint initiative to strengthen prevention, reporting, and management of occupational cancer. This consensus provides a structured framework for assessing the occupational origin of cancer, facilitating case notification and classification as occupational contingencies, and supporting informed evaluations of disability and work reintegration in patients with cancer. The collaboration between both societies aims not only to advance occupational cancer prevention but also to promote evidence-based strategies for return-to-work planning.
期刊介绍:
Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.